{
    "nctId": "NCT01711710",
    "briefTitle": "Clinical Trial to Evaluate the Safety and Efficacy of Breast Implant",
    "officialTitle": "Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implant (CoSBI) in Women Aged 22 and Over With Breast Reconstruction or Augmentation Mammoplasty.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 103,
    "primaryOutcomeMeasure": "a rate of rupture of 1%",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Over 22 years of age\n* Subjects who want breast augmentation reconstruction following breast cancer, congenital or accidental unbalanced breast size\n* Negative pregnancy test in fertile women\n* Subjects who voluntarily decided the participation of the study and signed the informed consent\n* Subjects who can understand and comply with the instructions and participate during the entire period of the trial\n\nExclusion Criteria:\n\n* previous breast reconstruction or augmentation history\n* self -immune disease\n* uncontrolled active infectious disease\n* unable to insert beast implant due to radiotherapy\n* Patients who have recurrent breast cancer or do not treat effectively their cancer\n* Keloid\n* Abnormal blood test or ECG result for general anesthesia\n* Patients who cannot MRI scan due to having Metallic substance in the body or Claustrophobia\n* Aesthetic addiction, drug abuse, alcohol abuse\n* Patients who are not eligible for this study at the medical discretion of the Principal Investigator or Sub-investigator",
    "sex": "FEMALE",
    "minimumAge": "22 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}